transcription factors such as Stat3, and components of the Larry A.Feig 2 endocytic machinery such as clathrin (Wilde et al., 1999) 
Introduction
possibility that Ral-GTPases might be involved could be inferred only from very indirect evidence. First, the two Many, if not most, signaling molecules can be modulated proteins have similar cellular distributions. The majority by a wide variety of extracellular signals and can interact of both c-Src and Ral is present on the cytoplasmic face directly with and influence the activity of a large number of intracellular vesicles, with a small fraction present in of cellular target proteins. Understanding how individual the plasma membrane at any time (Feig and Emkey, signaling inputs can generate unique cellular responses 1993; Weernink and Rijksen, 1995) . Among intracellular under these conditions is a major challenge in signal vesicles, both proteins are enriched in endosomes and transduction research. The non-receptor tyrosine kinase, synaptic vesicles (Kaplan et al., 1992; Linstedt et al., c-Src , represents a good paradigm for this problem Bielinski et al., 1993; Onofri et al., 1997; review, see Brown and Cooper, 1996) , since it is activated Foster-Barber and Bishop, 1998) . Secondly, elevated Ralin response to diverse stimuli such as tyrosine kinase specific guanine nucleotide exchange factor (Ral-GEF) receptors, G-protein-linked receptors (Luttrell et al., 1997) , activity (Goi et al., 1999) and elevated activity of the integrins (Schlaepfer and Hunter, 1997) and estrogen c-Src substrate, Stat3 (Ihara et al., 1997) , generate the receptors (Migliaccio et al., 1996) . In addition, c-Src same phenotype in PC12 cells, inhibition of nerve growth activity can promote the phosphorylation of a wide variety of proteins, such as cell surface receptors for epidermal factor (NGF)-induced neurite outgrowth.
Two highly similar (85% identity) GTPases, RalA and RalB, constitute a distinct family of Ras-related proteins (Bos, 1997) , and as such they cycle between active GTPand inactive GDP-bound forms. Ral proteins are activated by Ral-GEFs, many of which contain Ras-binding sites. A growing body of evidence supports the idea that activation of Ral-GEFs initiates a downstream signaling pathway distinct from that of Ras (Urano et al., 1996; Wolthuis et al., 1997 Wolthuis et al., , 1998b . However, Ras-independent activation pathways to Ral also exist (Hofer et al., 1998; vector (C) , vector expressing the Ral-specific exchange factor Rgr, a Wolthuis et al., 1998a) .
constitutively activated Ral allele, RalA72L, or a dominant-negative
In general, elevated Ral-GEF activity is associated with Ral allele, Ral28N, along with HA-tagged Stat3. After 48 h, the cells enhanced cell proliferation (Urano et al., 1996; White were treated with either buffer or IL-6 (10 ng/ml) for 10 min. The et D'Adamo et al., 1997; Wolthuis et al., 1997;  tagged Stat3 was then immunoprecipitated and blotted with antiphosphotyrosine-specific Stat3 antibodies (p-Stat3). Total HA-Stat3 Goi et al., 1999) . Ral-GEF activity is also involved in expression (Stat3) in all of the experiments is shown at the bottom.
insulin regulation of the forkhead transcription factor
The data represent the results of at least three independent (Kops et al., 1999) . Ral GTPases interact with at least experiments.
three distinct cellular proteins that could carry out these actions: phospholipase D (PLD) (Jiang et al., 1995; Luo et al., 1998) , a GAP for CDC42 and Rac GTPases called is analogous to Ras17N, was transiently transfected along RalBP1 (also called RLIP or RIP) (Cantor et al., 1995;  with HA-Stat3. The cells were then stimulated with Jullien-Flores et al., 1995; Park and Weinberg, 1995) and IL-6. Expression of dnRal blocked IL-6-induced tyrosine filamin-α (also called ABP-280), one of a family of actinphosphorylation of HA-Stat3 (Figure 1 , top). These results cross-linking proteins (Gorlin et al., 1990; Takafuta et al., showed that Ral signaling participates in cytokine receptor-1998; Xie et al., 1998) . Ral-GTP can generate filapodiainduced tyrosine phosphorylation of Stat3. like structures possibly by recruiting filamin into the filapodial cytoskeleton (Ohta et al., 1999) .
Ral activates c-Src in 293 epithelial cells and 3Y1
In this study, we demonstrate that Ral-GTPases play an fibroblasts important role in the activation of c-Src by EGF receptors, A growing body of evidence supports the idea that tyrosine but not by β 2 -adrenergic receptors. We also show that phosphorylation of Stat proteins can be mediated by the signaling downstream from c-Src can differ, depending activation of the non-receptor tyrosine kinase c-Src (Yu upon which extracellular signal is responsible for its et al., 1995; Cirri et al., 1997; Bromberg et al., 1998; activation in cells. Chaturvedi et al., 1998; Turkson et al., 1998) . To test whether Ral regulates c-Src activity, HEK293 cells were
Results
used because they can be transfected at high enough efficiency (~70%) to measure the effects of Ral on Ral activity modulates Stat tyrosine endogenous signaling proteins. The Ral-GEF, Rgr or phosphorylation in PC12 cells RalA72L were transiently transfected into HEK293 cells The first suggestion that Ral proteins influence tyrosine and 48 h later c-Src was immunoprecipitated and assayed kinase signaling came from our recent finding that the in vitro for tyrosine kinase activity on denatured enolase effects of elevated Ral-GEF activity in PC12 cells mimic as substrate. Expression of Rgr or constitutively activated those of activated Stat3 (Ihara et al., 1997; Goi et al., RalA enhanced c-Src activity by~2-fold, while EGF 1999). Therefore, to test whether Ral signaling modulates treatment increased its activity~3-fold ( Figure 2A ). Since tyrosine phosphorylation of Stat3, PC12 cells were transionly~70% of the cells were transfected with Rgr or ently transfected with a vector encoding hemagglutinin Ral72L, while all of the cells were exposed to EGF, the (HA)-tagged Stat3 along with vectors encoding either an three stimuli actually had comparable effects on c-Src active Ral-GEF, Rgr, or a constitutively activated allele activation. of RalA, RalA72L. HA-Stat3 was immunoprecipitated 3Y1 rat fibroblasts stably expressing the EGF receptor 2 days later and then immunoblotted with anti-phospho-[3Y1(EGFR)] were also used to demonstrate an effect of tyrosine-specific Stat3 antibodies. Both activators of the Ral on c-Src activity. c-Src activity was measured in Ral signaling pathway increased tyrosine-phosphorylated control cells and in cells stably expressing RalA72L. Stat3 to levels that were comparable to those obtained Serum-starved 3Y1(EGFR) cells expressing RalA72L disupon treatment of cells with interleukin-6 (IL-6), a known played~1.6-fold higher c-Src activity than control cells. activator of Stat3 in PC12 cells (Figure 1, top) . ImmunoThis increase was similar to that observed when control blotting for total Stat3 showed that equal levels of the cells were stimulated with EGF ( Figure 2B , top). Comtranscription factor were present in all samples parable levels of c-Src were detected in all samples (Figure 1, bottom) .
( Figure 2B , bottom). Since these results argued that Ral has the capacity Since Ras is known to promote the GTP-bound state to promote tyrosine phosphorylation of Stat3, we next of Ral in cells, we also demonstrated that RasH61L tested whether tyrosine phosphorylation of Stat3 by stimulates c-Src activity to a degree similar to that of in PC12 cells is dependent upon Ral-GEF activity. To RalA72L in transiently transfected 293 cells ( Figure 2C ). suppress Ral-GEF's ability to activate Ral in cells, RalA28N, a dominant-negative (dn) form of Ral, which RasH12V37G, an effector mutant of activated Ras that Figure 2 . Total c-Src levels in cells or RalA72L. After 24 h, the cells were serum starved (0.5%) for 12 h lysates are shown below. Below that are immunoblots of these lysates and then some cells were treated with EGF for 10 min. The cells were using phospho-specific ERK antibodies. (C) The experiments were lysed and c-Src was immunoprecipitated. The immunoprecipitates performed as in (A) except that Ras17N was substituted for Ral28N. were used in a kinase assay in vitro using denatured enolase as
The data are representative of at least three independent experiments. substrate. The labeled reaction was then run on SDS-gels, and exposed to a phosphoimager. The fold increase in enolase phosphorylation compared with control sample (C) is marked on top
Ral-GEF activity is required for EGF receptor, but
of the radioactive image. Bottom: data from at least three independent not β 2 -adrenergic receptor, activation of c-Src experiments were pooled and plotted with standard errors of the mean EGF activates c-Src, but the mechanism involved is not This value is an underestimate of the true inhibitory effect of the protein since only~70% of cells were transfected with dnRal while all of the cells were stimulated with EGF. These findings were confirmed in 3Y1(EFGR) cells, preferentially activates Ral-GEFs over other Ras effectors, also stimulated the kinase activity of c-Src in these cells.
where the stable expression of inhibitory RalA28N also suppressed EGF-induced activation of c-Src by~75% In contrast, RasH12V35S, which preferentially activates Raf kinase over other Ras effector proteins, did not activate ( Figure 3B ). Importantly, EGF activation of Erk was not blocked in the same cells ( Figure 3C ), demonstrating clear c-Src in this system, demonstrating specificity between Raf and Ral-GEF signaling ( Figure 2C ). Comparable specificity in the effects of Ral on EGF receptor signaling. Ligands that activate G-protein-linked receptors also levels of Ras mutants were expressed in all transfected cells ( Figure 2C, bottom) activate c-Src. In particular, β 2 -adrenergic receptors have recently been shown to activate c-Src by promoting its binding to the adaptor protein arrestin. To determine whether β 2 -adrenergic receptor activation of c-Src is also dependent upon Ral activity, 293 cells were transfected as above except that the cells were stimulated with the β 2 -adrenergic receptor agonist, isoproterenol. In contrast to EGF stimulation, isoproterenol stimulation of c-Src activity (2.9-fold) was not affected by the expression of dnRal ( Figure 3A ). Since EGF activates Ral through the activation of Ras (Bos, 1998) , the dependence of EGF-induced c-Src activation on Ras was determined by the expression of dnRas17N in 293 cells as described above. EGF activation of c-Src was suppressed by expression of dnRas17N, consistent with EGF activating c-Src through a Ras/ Ral-mediated signaling cascade ( Figure 3C ). In contrast, c-Src is capable of activating a wide variety of signaling molecules and signaling pathways through its tyrosine actin cytoskeleton, such as the actin-binding protein kinase activity. These include Stat transcription factors cortactin. Transient expression of activated RalA72L into (Garcia and Jove, 1998), components of the actin cyto-293 cells increased the tyrosine phosphorylation of skeleton such as cortactin (Belsches et al., 1997) , and the cortactin, and transient expression of dnRal in these Shc adaptor protein that can lead to the activation of the cells suppressed the tyrosine phosphorylation of cortactin Ras/Raf/Erk signaling cascade (Luttrell et al., 1996 ; Cary induced by EGF ( Figure 5A ). Thus, Ral also couples and Guan, 1999). To determine whether the mechanism EGF receptors to Src effects on the cytoskeletal protein, of c-Src activation can influence the specificity of downcortactin. stream signaling from c-Src, Ral and β-adrenergic recepc-Src can also activate the Erk kinase by promoting tors were compared for their ability to promote the the tyrosine phosphorylation of the Shc adaptor protein phosphorylation of known targets of c-Src. (Luttrell et al., 1996; Schlaepfer and Hunter, 1997) . Using PC12 cells transfected with HA-Stat3, we already However, expression of Ral72L in transiently transfected demonstrated that Ral has the potential to influence this 293 cells did not enhance the tyrosine phosphorylation of c-Src-responsive transcription factor (see Figure 1 ). To Shc ( Figure 5B ). It also had no effect on Erk activity, as confirm that Ral activity controls the tyrosine phosphorylaassessed by reactivity of an activation-specific phosphotion of endogenous Stat3, complex formation between Erk antibody ( Figure 5B ). In addition, Figure 3C already c-Src and tyrosine-phosphorylated Stat3 was assessed.
showed that the expression of dnRal had no detectable effect on EGF activation of Erk in 3Y1(EGFR) cells. The RalA72L was transfected transiently into 293 cells, c-Src same result is shown here in 293 cells ( Figure 5C ). Thus, was immunoprecipitated from serum-starved cells and although Ral can activate c-Src in 293 and 3Y1(EGFR) then the sample was immunoblotted with anti-Stat3 anticells, this fraction of c-Src is not capable of activating the bodies. RalA72L promoted the association of c-Src with Shc/Ras/Erk signaling cascade. Stat3 to a level comparable to that seen after EGF Unlike Ral-activated c-Src, β-adrenergic receptortreatment ( Figure 4A ). Antibodies specific for tyrosineactivated c-Src has previously been shown to promote Shc phosphorylated Stat3 were used to confirm that RalA72L tyrosine phosphorylation and subsequent Erk activation. expression induced the tyrosine phosphorylation of endoHowever, isoproterenol addition to 293 cells did not genous Stat3 ( Figure 4A ). Similar conclusions were promote the association of c-Src with tyrosine-phosphorylobtained when serum-starved 3Y1(EGFR) cells stably ated Stat3 or the tyrosine phosphorylation of cortactin expressing RalA72L were compared with control ( Figure 6 ), even though under these conditions it did 3Y1(EGFR) cells ( Figure 4B) . activate c-Src (see Figure 3A and C) and Erk ( Figure 6 ). Moreover, expression of dnRal either transiently in 293
Therefore, EGF/Ral and β-adrenergic receptor promoted cells ( Figure 4A ) or stably in 3Y1(EGFR) cells ( Figure 4B) the phosphorylation of distinct subsets of potential c-Src suppressed EGF-induced association of c-Src with tyrosubstrates (see Figure 7 ). sine-phosphorylated Stat3. Together, these experiments clearly show that Ral activity plays a major role in Discussion coupling EGF receptors to c-Src-mediated tyrosine phosphorylation of the Stat3 transcription factor.
The results presented here demonstrate that individual cell surface receptors can influence distinct subsets of the Src is also known to phosphorylate regulators of the tyrosine phosphorylation of Stat3 and cortactin in these cells. We also showed that EGF and β 2 -adrenergic receptors activate c-Src by different mechanisms. The former, but not the latter, functions through a Ras-and Raldependent signaling pathway. These findings may begin to explain how signaling molecules such as c-Src, which affect diverse target proteins, can generate unique cellular effects in response to individual stimuli. It will be interesting to determine if the phenomena observed here can be generalized. For example, do c-Src proteins activated by other stimuli, such as platelet-derived growth factor (Walker, 1993; Weernink and Rijksen, 1995) , integrins (Schlaepfer and Hunter, 1997) , calcium (Rusanescu et al., 1995) , thrombin and estradiol (Migliaccio et al., 1996) also phosphorylate distinct sets of target proteins?
The discovery that Ral regulates c-Src was unexpected. Src has been thought of as an upstream regulator of the Ras/Raf/Erk signaling cascade for quite some time (Smith et al., 1986 ), yet Ral is best known as a downstream target of Ras. A major conclusion of this study is that function by Ras-independent pathways (Hofer et al., 1998; Wolthuis et al., 1998a; M'Rabet et al., 1999 ) (see Figure 7) . In such instances, the selective activation of c-Src substrates upon Ral activation could contribute to signaling flexibility by allowing c-Src to be activated without Ras and subsequent Erk activation.
Ral-GTPases have the potential to influence at least three downstream signaling molecules, RalBP1 (or RLIP and RIP), filamin (or ABP280) and PLD1. Which of these proteins is involved in c-Src activation, and how specificity in c-Src substrate phosphorylation is achieved remain to be determined. For β 2 -adrenergic receptors, activation of c-Src occurs as a consequence of binding to arrestin via the SH3 domain of c-Src. Why c-Src activated in this way leads to the tyrosine phosphorylation of Shc but not phosphorylated Shc leads to Ras activation, one would expect β 2 -adrenergic receptors to promote the tyrosine phosphorylation of cortactin and Stat3 through Rasmany potential downstream targets of c-Src. For example, c-Src activation by an EGF receptor/Ral-GTPase mediated Ral activation (see Figure 7) . The fact that this does not occur is probably due to the fact that Ral does signaling pathway promotes Stat3 and cortactin tyrosine phosphorylation in the cells we studied. However, c-Src not activate c-Src upon β 2 -adrenergic receptor stimulation. This can be inferred from our finding that expression of activated in this way does not lead to Shc tyrosine phosphorylation and subsequent activation of the Ras/Raf/ dnRal did not significantly suppress isoproterenol-induced c-Src activation. Like c-Src, Ral may also have the capacity Erk signaling pathway. In contrast, c-Src activated by β 2 -adrenergic receptors participates in the induction of to activate only a subset of potential downstream targets under distinct circumstances. Alternatively, Ral activation Shc phosphorylation and Erk activation, but not in the Fig. 7 . EGF and β-adrenergic receptors activate c-Src by different mechanisms that lead to the tyrosine phosphorylation of different sets of c-Src substrates. EGF receptors, but not β-adrenergic receptors (βAR), activate c-Src by a Ras-and Ral-dependent signaling pathway. Importantly, Ral-induced c-Src activation leads to Stat3 and cortactin tyrosine phosphorylation, but not Shc phosphorylation and Erk activation. In contrast, βAR activation of c-Src leads to Shc but not cortactin or Stat3 tyrosine phosphorylation. Ral can also be activated by Ras-independent pathways, such as through calcium, which would allow c-Src to activate downstream targets without activating Ras and its multiple effectors. Overall, these findings suggest how different receptors may generate specific cellular effects through a common kinase.
by ligands may be necessary for c-Src activation, but A large literature supports the idea that the Janus tyrosine kinases (JAKs) mediate Stat phosphorylation by not sufficient. The c-Src activation we observed upon expression of a constitutively activated allele of Ral or interleukins (Ihle, 1995) , suggesting that Ral proteins can also regulate this family of tyrosine kinases. However, Ral-GEF may reflect an extreme situation that obviates the need for a complementary signal that is normally c-Src can activate JAKs (Campbell et al., 1997) , raising the possibility that in PC12 cells Ral regulates JAKs supplied by EGF receptor but not β 2 -adrenergic receptor activation.
through c-Src in response to IL-6 stimulation. However, JAKs may not be involved at all since there is evidence Experiments in three different cell types, PC12 pheochromocytoma cells, 293 epithelial cells and 3Y1 for a primary role for Src in Stat activation during IL-3 and EGF stimulation of cells (Chaturvedi et al., 1998 ; fibroblasts, were used to confirm that Ral can regulate c-Src. In 293 and 3Y1 cells, c-Src activity was measured Olayioye et al., 1999) . Further analysis of Ral function in interleukin signaling may add insight into the relationdirectly, while in PC12 cells the tyrosine phosphorylation of transfected Stat3 was suggestive of c-Src activity. In ship between Src, JAK and Stat proteins. Unlike their Ras counterparts, constitutively activated each case, elevation of Ral-GTP levels activated c-Src, while suppression of Ral-GTP levels by expression of Ral alleles have not been considered as potential oncogenes because expression of the mutant protein by itself has not dnRal inhibited EGF-or IL-6-induced c-Src activation. The effect of dnRal on EGF receptor function was quite been found to enhance cell proliferation. However, Ral72L expression has been shown to enhance modestly focus specific since EGF activation of Erk was not affected in the same cell lysates where c-Src activation was blocked.
formation induced by expression of a weak Raf allele in NIH-3T3 cells (Urano et al., 1996) . Moreover, we have Previous studies focusing on Ral-and Ral-GEF-induced cell proliferation (Urano et al., 1996; White et al., 1996;  recently observed that constitutively activated Ral expression in 3Y1 cells overexpressing the EGF receptor Wolthuis et al., 1997) , fos or E2F promoter activation (Okazaki et al., 1997; Wolthuis et al., 1997; Gille, 1999) enhanced colony formation in semi-solid media (Lu et al., 2000) . In the present study, we showed that these cells and phosphorylation of the forkhead transcription factor (Kops et al., 1999) showed clear effects by Ral-GEFs but displayed elevated c-Src activity. This alteration may contribute to the cells' enhanced growth properties, since little or no effects by an activated allele of Ral. Thus, these studies left open the possibility that these effects a series of investigations have documented the synergistic effects of c-Src and EGF receptor activities on the transwere due to a function of Ral-GEFs other than Ral activation. This is not the case for c-Src activation formed phenotype of tissue culture cells (Roche et al., 1995; Belsches et al., 1997) . detected here, since a constitutively activated allele of RalA generated effects comparable to growth factor A variety of human tumor cell types, including carcinoma of the colon and mammary gland (Ottenhoffstimulation or Ral-GEF expression.
Although the major part of this study involved the Kalff et al., 1992; Muthuswamy and Muller, 1994; Muthuswamy et al., 1994; Watson and Miller, 1995 ; investigation of the role of Ral in c-Src activation by the EGF receptor, we also showed that in PC12 cells, dnRal Garcia et al., 1997; Biscardi et al., 1999b) , display elevated c-Src and Stat3 activity. Our finding that Ral can blocked IL-6-induced tyrosine phosphorylation of Stat3.
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